Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2269971
Max Phase: Preclinical
Molecular Formula: C24H33ClN2O4
Molecular Weight: 448.99
Molecule Type: Small molecule
Associated Items:
ID: ALA2269971
Max Phase: Preclinical
Molecular Formula: C24H33ClN2O4
Molecular Weight: 448.99
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC(=O)N(CCOc1ccc(CCOCC)cc1C)C(=O)c1c(Cl)c(C)cn1C
Standard InChI: InChI=1S/C24H33ClN2O4/c1-6-8-21(28)27(24(29)23-22(25)18(4)16-26(23)5)12-14-31-20-10-9-19(15-17(20)3)11-13-30-7-2/h9-10,15-16H,6-8,11-14H2,1-5H3
Standard InChI Key: NUYSZKSZEGVLKZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 448.99 | Molecular Weight (Monoisotopic): 448.2129 | AlogP: 4.72 | #Rotatable Bonds: 11 |
Polar Surface Area: 60.77 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.20 | CX LogD: 5.20 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.47 | Np Likeness Score: -0.74 |
1. OBATA T, FUJII K, FUNAKI E, TSUTSUMIUTI K, OHOKA A, SUIZU S, KANETSUKI Y. (1999) Synthesis and Selective Bioactivity of New Pyrazolecarboxamide Derivatives, 24 (1): [10.1584/jpestics.24.33] |
Source(1):